Skip to main content
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Default Author Avatar IUSM Logo
Author

Jackie Maupin

Jackie supports the Herman B Wells Center for Pediatric Research at IU School of Medicine. As communications generalist, Jackie helps spread the word about the Wells Center's commitment to improving the health of children in Indiana and beyond through basic and translational research. She has several years of experience in non-profit and academic marketing and communications. 

Showing results for Jackie Maupin

Wells Center Newsletter | February 2024

February 2024 news and updates from the Herman B Wells Center for Pediatric Research.

Jackie Maupin  |  Feb 15, 2024

New study uncovers key cells in the heart’s link to several body systems

In a recent Nature Communications article, IU School of Medicine researchers collaborated with scientists from the UK, China and France on an investigation that uncovered an unexpected link between the cells in the heart and other systems of the body.

Jackie Maupin  |  Dec 14, 2023

Wells Center Newsletter | November 2023

Keep up with the Herman B Wells Center for Pediatric Research by reading our latest newsletter for updates on exciting research, recent grants, publications and much more!

Jackie Maupin  |  Nov 16, 2023

Andrea Conroy honored as 2023 Bailey K. Ashford Medalist 

In October 2023, Andrea Conroy, PhD, an assistant professor of pediatrics at Indiana University School of Medicine was honored with the prestigious Bailey K. Ashford Medal by the American Society of Tropical Medicine and Hygiene (ASTMH). This accolade celebrates her distinguished contributions to the field of tropical medicine. 

Jackie Maupin  |  Nov 15, 2023

Clinical trial presents a pill of promise for type 1 diabetes

In March 2023, 10-year-old Emmaline Swigert was diagnosed with type 1 diabetes, an autoimmune disease where the body’s immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. Today, Emmaline is participating in an Indiana University School of Medicine-led clinical trial aimed at testing a pill that could help make life much easier for individuals like her living with the condition.

Jackie Maupin  |  Nov 13, 2023

Pediatric perspectives on low-carb diets for kids with or at risk of diabetes

In a recently published Pediatrics clinical report, the American Academy of Pediatrics (AAP) represented by Indiana University School of Medicine professor of pediatrics Tamara Hannon, MD, examined the suitability of low-carb diets for children and adolescents with type 1 diabetes or those who are overweight and susceptible to type 2 diabetes.

Jackie Maupin  |  Oct 02, 2023

Delaying diabetes: new treatment makes its mark in Indiana

In August 2023, a Riley Hospital for Children patient became the first child in Indiana to receive teplizumab, a groundbreaking therapy that delays the onset of stage 3 type 1 diabetes by an average of three years. The treatment received Federal Drug Administration approval in November 2022, three years after Indiana University School of Medicine researchers conducted clinical trials and published data that helped lead to the FDA’s decision.

Jackie Maupin  |  Sep 25, 2023

Wells Center bestows scientists with awards to fuel pediatric research

The Wells Center for Pediatric Research has recognized several researchers with awards during their spring 2023 round of funding to support five promising projects focused on emerging therapies and clinical and translational pediatric research.

Jackie Maupin  |  Aug 31, 2023

Wells Center Newsletter | August 2023

August 2023 news and updates from the Herman B Wells Center for Pediatric Research.

Jackie Maupin  |  Aug 17, 2023

IU researchers uncover mysteries behind immune response to hemophilia A treatment

In a study published in Blood, researchers from Indiana University School of Medicine shed new light on the underlying causes of negative immune responses to factor VIII treatments, providing valuable insights that could lead to more effective and safer hemophilia A treatments in the future. 

Jackie Maupin  |  Aug 10, 2023